P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans

P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans

Bibliographic Details
Main Authors:	Ertl HC, Casimiro DR, Robertson MN, Ratcliffe S, Cox K, Dubey S, Carnathan D, Hutnick N, Betts MR
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality.
by: Natalie A Hutnick, et al.
Published: (2010-12-01)

Increased mucosal CD4+ T-cell activation following vaccination with an adenoviral vector in rhesus macaques
by: Bukh I, et al.
Published: (2012-09-01)

Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and Adenovirus (Ad5) immune mice
by: Schuldt Nathaniel J, et al.
Published: (2012-06-01)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
by: Penaloza P, et al.
Published: (2012-09-01)

Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
by: Lisa Koodie, et al.
Published: (2019-02-01)

Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration.
by: Piergiuseppe Nestola, et al.
Published: (2014-01-01)

Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.
by: Eric A Weaver, et al.
Published: (2013-01-01)

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
by: Sam Afkhami, et al.
Published: (2016-01-01)

Identification of genes differentially expressed as result of adenovirus type 5- and adenovirus type 12-transformation
by: Kellam Paul, et al.
Published: (2009-02-01)

P19-35. Replicating adenovirus type 5 host range recombinant vaccine biodistribution in rhesus macaques following multiple mucosal routes of immunization
by: Haase AT, et al.
Published: (2009-10-01)

P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
by: Betts MR, et al.
Published: (2009-10-01)

Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
by: K. Jagannadha Sastry, et al.
Published: (2009-11-01)

Mucosal and systemic immune responses induced by immunisation of cotton rats with recombinant adenoviruses
by: Papp, Zsuzsanna
Published: (1998)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
by: Hua Zhao, et al.
Published: (2018-03-01)

Investigation of latent adenovirus 5 infection in guinea pig lung
by: Behzad, Hayedeh
Published: (2009)

Isolation and Characterisation of Host Range Mutants of Adenovirus Type 5
by: Harrison, T. J.
Published: (1976)

Investigation of latent adenovirus 5 infection in guinea pig lung
by: Behzad, Hayedeh
Published: (2009)

The expression and function of the adenovirus type 5 E4 region
by: Dix, Ian
Published: (1994)

Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.
by: Yoshiko Fukuyama, et al.
Published: (2013-01-01)

Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin
by: Simonsson Monika, et al.
Published: (2007-03-01)

A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease model.
by: Ami Patel, et al.
Published: (2010-12-01)

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
by: Andrew W Harmon, et al.
Published: (2018-01-01)

Remembering Johannes Manjrekar (5 June 1957–09 February 2020)
by: Sushma Naithani
Published: (2021-06-01)

MARGARITA PAVLOVNA BREZGINA (5.09.1937 – 27.11. 2003)
by: Team of "Slovesnik"
Published: (2004-08-01)

In memoriam: Aina Blinkena (5.09.1929 – 22.11.2017)
by: Ilga Jansone
Published: (2018-12-01)

In Memorian: Harry Keen (3.09.1925?5.04.2013)
by: Zamira Tamrazovna Zuraeva, et al.
Published: (2013-11-01)

Temporal dynamics of adenovirus 5 gene expression in normal human cells.
by: Leandro Crisostomo, et al.
Published: (2019-01-01)

Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5
by: Yun Lv, et al.
Published: (2019-04-01)

The 5′UTR in human adenoviruses: leader diversity in late gene expression
by: Mirja Ramke, et al.
Published: (2017-04-01)

Adrenal gland infection by serotype 5 adenovirus requires coagulation factors.
by: Lucile Tran, et al.
Published: (2013-01-01)

CAR modulates E-cadherin dynamics in the presence of adenovirus type 5.
by: Fawziyah Hussain, et al.
Published: (2011-01-01)

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells
by: Jian Gao, et al.
Published: (2020-09-01)

5th INTERNATIONAL CONGRESS „FLOUR-BREAD '09“AND 7th CROATIAN CONGRESS OF CEREAL TECHNOLOGISTS „FLOUR-BREAD '09“
Published: (2009-01-01)

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.
by: Samuel O Pine, et al.
Published: (2011-04-01)

CCL5 regulation of mucosal chlamydial immunity and infection
by: Igietseme Joseph U, et al.
Published: (2008-08-01)

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
by: Aseem Pandey, et al.
Published: (2012-01-01)

ALEXANDR S. AVRUNIN. 16.12.1947 – 17.09.2017
Published: (2017-12-01)

Impedance and modulus studies of Na0.9Ba0.1Nb0.9(Sn0.5Ti0.5)0.1O3 ceramic
by: A. Oueslati, et al.
Published: (2021-04-01)

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).
by: Laurence Peiperl, et al.
Published: (2010-10-01)

Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases
by: Gerritsen Winald R, et al.
Published: (2008-01-01)